Download FREE Report Sample
Download Free sampleThe Global "Newborn Genetic Screening Market" was valued at USD 1.42 Billion in 2023 and is projected to reach USD 2.14 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period (2024-2030). The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Newborn genetic screening is a medical test performed on newborns to detect genetic, metabolic, and other congenital disorders early in life. This helps in the timely treatment and management of conditions that might otherwise lead to severe health problems or developmental issues.
Influence of COVID-19: The impact of the COVID-19 pandemic has been considered in the estimation of market sizes, likely affecting supply chains, healthcare practices, and funding.
Impact of the Russia-Ukraine War: The ongoing conflict between Russia and Ukraine has also been factored into the market analysis, potentially influencing economic stability and international trade.
Drivers of Growth: Factors driving the market growth include increasing awareness about early detection of genetic disorders, technological advancements in genetic screening, and government initiatives for newborn health.
Technological Advancements: Innovations in genetic testing technologies, such as next-generation sequencing (NGS), are enhancing the accuracy and efficiency of newborn genetic screening.
Government Initiatives: Many countries have implemented mandatory newborn screening programs, which are expected to boost market growth.
Challenges: Challenges include high costs of advanced genetic tests, limited access to screening in low-income regions, and ethical concerns related to genetic testing.
Regional Insights: North America and Europe are expected to hold significant market shares due to established healthcare infrastructure and government support, while the Asia-Pacific region is projected to exhibit substantial growth owing to increasing healthcare investments and awareness.
The global key manufacturers of Newborn Genetic Screening include Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth, NJ.gov, Agilent Technologies, Ge Healthcare, PERKINELMER and Natus Medical Incorporated, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Newborn Genetic Screening Market aims to provide a comprehensive presentation of the global market for Newborn Genetic Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Genetic Screening. Newborn Genetic Screening Market contains market size and forecasts of Newborn Genetic Screening in global, including the following market information:
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Newborn Genetic Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Newborn Genetic Screening Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Newborn Genetic Screening Market Segment Percentages, by Type, 2023 (%)
Global Newborn Genetic Screening Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Newborn Genetic Screening Market Segment Percentages, by Application, 2023 (%)
Global Newborn Genetic Screening Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Newborn Genetic Screening Market Segment Percentages, By Region and Country, 2023 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Newborn Genetic Screening, market overview.
Chapter 2: Global Newborn Genetic Screening market size in revenue.
Chapter 3: Detailed analysis of Newborn Genetic Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Newborn Genetic Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy